Amyloid-beta modulates microglial responses by binding to the triggering receptor expressed on myeloid cells 2 (TREM2)
Year: 2018
Type: article
Abstract: TREM2 is an innate immune receptor specifically expressed in microglia. Coding variations in TREM2 have been reported to increase the risk for Alzheimer’s disease (AD) and other neurodegenerative diseases. While multiple studies support a role for TREM2 in microglial recruitment to amyloid plaques, the chemoattractant factor modulating TREM2-dependent microglial responses has not been defined. Potential binding of oligomeric amyloid-β 1–42 (oAβ 1–42 ) to TREM2 was tested by complementary approaches including solid phase binding, surface plasmon resonance and immunoprecipitation assays. The ability of oAβ 1–42 to activate TREM2 signaling pathways was examined by analyzing the phosphorylation of Syk and Akt in primary microglia as well as TREM2-mediated signaling in a reporter cell system. Lastly, the functional outcome of oAβ 1–42 -TREM2 interaction was tested by examining impacts on microglial migration in vitro and clustering around oAβ 1–42 -bearing brain areas in vivo. We found that oAβ 1–42 bound to TREM2 with high affinity and activated TREM2-dependent signaling pathway. Neither monomeric nor scrambled Aβ bound to TREM2 supporting a specific interaction between oAβ and TREM2. The disease-associated mutations of TREM2 reduced its binding affinity to oAβ 1–42 . Furthermore, we identified several positively charged amino acids within residues 31–91 of TREM2 that were crucial for its interaction with oAβ 1–42 . Importantly, oAβ 1–42 promoted microglial migration in vitro and clustering in vivo in a TREM2-dependent manner. Our data establish a critical link between oAβ 1–42 , a major pathological component of AD, and TREM2, a strong genetic risk factor for AD expressed in microglia, and suggest that such interaction contributes to the pathogenic events in AD by modulating microglial responses.
Source: Molecular Neurodegeneration
Authors: Li Zhong, Zongqi Wang, Daxin Wang, Zhe Wang, Yuka A. Martens, Linbei Wu, Ying Xu, Kai Wang, Jianguo Li, Ruizhi Huang, Dan Can, Huaxi Xu, Guojun Bu, Xiao-Fen Chen
Language: English
Subfield: Neurology
Field: Neuroscience
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $3,090
Funders: Cure Alzheimer's Fund, National Natural Science Foundation of China, China Postdoctoral Science Foundation, Natural Science Foundation of Guangdong Province, Xiamen University, National Institutes of Health, Fundamental Research Funds for the Central Universities, National Institute on Aging
Awards: Molecular pathobiology of soluble TREM2 in Alzheimer's disease, G252622260, ApoE pathway in cerebrovascular Aβ clearance in Alzheimer's disease, G2993685112, G3452454666, G358263164, APP分泌酶基因的转录调控研究, G3769827772, G5647792941, G7456404772, G7510283151, G7582350918, BAC Transgenic Mouse Models of TREM2 to Study Neuroprotective Mechanisms in AD, ApoE and LRP1 in brain insulin signaling and glucose metabolism (Competitive Renewal), KOMP2-Phase3 Production and Phenotyping by the DTCC Consortium., G964195463
OpenAlex ID: W2803198382
